ImpediMed IPDQF Stock
ImpediMed Price Chart
ImpediMed IPDQF Financial and Trading Overview
| ImpediMed stock price | 0.08 USD |
| Previous Close | 0.11 USD |
| Open | 0.1 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.1 - 0.11 USD |
| 52 Week Range | 0.04 - 0.13 USD |
| Volume | 190K USD |
| Avg. Volume | 89K USD |
| Market Cap | 218.17M USD |
| Beta (5Y Monthly) | 2.949808 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IPDQF Valuation Measures
| Enterprise Value | 171.31M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 19.788925 |
| Price/Book (mrq) | 4.8869567 |
| Enterprise Value/Revenue | 15.539 |
| Enterprise Value/EBITDA | -7.552 |
Trading Information
ImpediMed Stock Price History
| Beta (5Y Monthly) | 2.949808 |
| 52-Week Change | 119.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.13 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.1 USD |
| 200-Day Moving Average | 0.06 USD |
IPDQF Share Statistics
| Avg. Volume (3 month) | 89K USD |
| Avg. Daily Volume (10-Days) | 173.96K USD |
| Shares Outstanding | 1.94B |
| Float | 1.59B |
| Short Ratio | N/A |
| % Held by Insiders | 13.89% |
| % Held by Institutions | 14.95% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1027:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -197.45% |
| Operating Margin (ttm) | -214.75% |
| Gross Margin | 87.00% |
| EBITDA Margin | -205.75% |
Management Effectiveness
| Return on Assets (ttm) | -25.57% |
| Return on Equity (ttm) | -43.69% |
Income Statement
| Revenue (ttm) | 11.03M USD |
| Revenue Per Share (ttm) | 0.006 USD |
| Quarterly Revenue Growth (yoy) | 8.79% |
| Gross Profit (ttm) | 9.16M USD |
| EBITDA | -22685000 USD |
| Net Income Avi to Common (ttm) | -21696000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.2M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 1.33M USD |
| Total Debt/Equity (mrq) | 3.26 USD |
| Current Ratio (mrq) | 5.469 |
| Book Value Per Share (mrq) | 0.023 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21575000 USD |
| Levered Free Cash Flow (ttm) | -18146124 USD |
Profile of ImpediMed
| Country | United States |
| State | QLD |
| City | Pinkenba |
| Address | 50 Parker Court |
| ZIP | 4008 |
| Phone | 61 7 3860 3700 |
| Website | https://www.impedimed.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 73 |
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Q&A For ImpediMed Stock
What is a current IPDQF stock price?
ImpediMed IPDQF stock price today per share is 0.08 USD.
How to purchase ImpediMed stock?
You can buy IPDQF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImpediMed?
The stock symbol or ticker of ImpediMed is IPDQF.
Which industry does the ImpediMed company belong to?
The ImpediMed industry is Medical Devices.
How many shares does ImpediMed have in circulation?
The max supply of ImpediMed shares is 2.02B.
What is ImpediMed Price to Earnings Ratio (PE Ratio)?
ImpediMed PE Ratio is now.
What was ImpediMed earnings per share over the trailing 12 months (TTM)?
ImpediMed EPS is 0 USD over the trailing 12 months.
Which sector does the ImpediMed company belong to?
The ImpediMed sector is Healthcare.